T1	Outcomes 1101 1120	mean FVIIa activity
T2	Outcomes 1235 1260	pharmacokinetics of N7-GP
T3	Outcomes 1329 1351	serious adverse events
T4	Outcomes 1418 1432	adverse events
T5	Outcomes 1486 1523	neutralizing antibodies against N7-GP